Immuno-Biological Laboratories Co., Ltd.
Immuno-Biological Laboratories Co., Ltd.
Aktie · JP3921300004 (XTKS)
Übersicht
Kein Kurs
Schlusskurs XTKS 05.02.2026: 1.515,00 JPY
05.02.2026 00:00
Aktuelle Kurse von Immuno-Biological Laboratories Co., Ltd.
BörseTickerWährungLetzter UmsatzKursTagesveränderung
XTKS: Tokyo
Tokyo
4570.T
JPY
05.02.2026 00:00
1.515,00 JPY
0,00 JPY
Free Float & Liquidität
Free Float 79,42 %
Shares Float 7,4 M
Ausstehende Aktien 9,31 M
Firmenprofil zu Immuno-Biological Laboratories Co., Ltd. Aktie
Immuno-Biological Laboratories Co., Ltd. engages in the research, development, manufacturing, and supply of various immunological research reagents worldwide. The company offers ELILSA, an assay kit to quantitatively measure targeted substances; and support research services on Alzheimer's disease, metabolic syndrome, and cancer, as well as customized services for production of customized antibodies and development of ELISA systems. It also provides LipoSEARCH, a customized services for profiling and analyzing of lipoprotein through gel-filtration high performance liquid chromatography method that can profile various clinical samples, such as tiny plasma or serum samples from both small animals and human beings for broad range of research fields including lipid metabolism, development of drugs for life-style related diseases, development of functional supplemental foods, and clinical studies. In addition, the company offers LipoTEST, a support tool for diagnostic and health checks at animal clinics; and customized biomarker testing services for Life-style related diseases. Further, it operates protein production business using transgenic silkworms for manufacturing of antibodies for research reagents and diagnostic products; human collagen for cosmetic materials; development of proteins for use in drugs; and other proteins production. The company was incorporated in 1982 and is headquartered in Fujioka, Japan.
KI-Analyse von Immuno-Biological Laboratories Co., Ltd.
Wähle eine Analyse aus und der finAgent liefert dir tiefgehende Einblicke dazu!
Neuste KI Analysen zu Immuno-Biological Laboratories Co., Ltd.
Für dieses Unternehmen sind noch keine KI-Threads verfügbar.

Unternehmensdaten

Name Immuno-Biological Laboratories Co., Ltd.
Firma Immuno-Biological Laboratories Co., Ltd.
Website https://www.ibl-japan.co.jp
Heimatbörse XTKS Tokyo
ISIN JP3921300004
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Tsutomu Seito
Marktkapitalisierung 15 Mrd.
Land Japan
Währung JPY
Mitarbeiter 0,1 T
Adresse Fujioka Laboratory, 375-0005 Fujioka
IPO Datum 2007-08-15

Ticker Symbole

Name Symbol
Tokyo 4570.T
Weitere Aktien
Investoren, die Immuno-Biological Laboratories Co., Ltd. halten, haben auch folgende Aktien im Depot:
GLOBAL SMALL-CAP INDEX FUND - INVESTOR EUR ACC
GLOBAL SMALL-CAP INDEX FUND - INVESTOR EUR ACC Fonds
IBERO MINING CORP
IBERO MINING CORP Aktie
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2026